Annik Caliezi | Clinical Trials | Best Researcher Award

Published on 28/03/202528/03/2025 by Top Pharmaceutical

Annik Caliezi | Clinical Trials | Best Researcher Award

Ms. Annik Caliezi, Dermatologie Inselspital, Switzerland

Annik Caliezi is a dedicated medical student in her 10th semester of the Master of Medicine program at the University of Bern. She holds a Bachelor’s in Medicine and a bilingual Matura in Economics and Law. With hands-on experience as a nursing assistant at Careanesth and an OR assistant in hand surgery, Annik has also contributed to histology and anatomy education. Her research focuses on Hidradenitis Suppurativa and its impact on sexual quality of life, with publications in MDPI. Fluent in German, English, and French, she holds multiple life support certifications. 🔬📚

Publication Profile

orcid

Education

Ms. Annik Caliezi 🎓 is currently in the 10th semester of her Master of Medicine at the University of Bern 🏥, where she has been pursuing her studies since 2023. Prior to this, she completed her Bachelor of Medicine (2020–2023) at the same institution, building a strong foundation in medical sciences 🔬. Her academic journey began with a bilingual Matura in Economics and Law 📚⚖️ at Gymnasium Kirchenfeld Bern (2015–2019), where she developed analytical and interdisciplinary skills. With a passion for medicine and a commitment to excellence, she continues to advance in her medical education and training. 🚀

Experience

Ms. Annik Caliezi 🏥 has gained diverse work experience in healthcare and beyond. Since May 2024, she has been working as a nursing assistant at Careanesth 🩺, and since May 2023, she has served as an OR Assistant in Hand Surgery at Permanence Hospital Hirslanden Bern ✋🏽🔬. Previously, she assisted in histology and anatomy courses at the University of Bern (10/2022–05/2023) 🧫📚. Since December 2021, she has been interning at Bahnhofpraxis Wichtrach 🚑. Her earlier experiences include a geriatric rehabilitation internship (2021) 👵🏼, a role as a waitress (2019–2020) ☕, and an activity therapy internship (2018) 🏡.

Awards

Ms. Annik Caliezi 🏥 has earned several valuable certifications in healthcare and language proficiency. In 2024, she became an Immediate Life Support (ILS) Provider through the European Resuscitation Council 🚑. She also completed the French course “Français pour futur médecin” (2023) 🩺🇫🇷, enhancing her medical communication skills. Additionally, she holds Basic Life Support (BLS) Provider certifications from 2021 and 2022 🏥🆘. Beyond medical training, she achieved Cambridge English Advanced (C1) – Grade A in 2019 📖🇬🇧. These certifications reflect her commitment to excellence in both emergency care and multilingual communication in the medical field. 🚀

Research Focus

Ms. Annik Caliezi’s research primarily focuses on dermatology 🩺, with a specific emphasis on hidradenitis suppurativa (HS) 🔬, a chronic inflammatory skin disease. Her work examines the impact of HS on sexual quality of life ❤️, addressing the psychological, emotional, and physical challenges faced by patients. Through her studies, she highlights the burden of HS 🤕, emphasizing the need for better patient care, awareness, and treatment strategies 📢. Her research contributes to dermatological advancements, aiming to improve both clinical outcomes and overall well-being 😊 for individuals affected by this debilitating condition.

Publication Top Notes

Impact of Hidradenitis Suppurativa on Sexual Quality of Life

Michael Harrison | Precision Medicine | Best Researcher Award

Published on 28/03/202528/03/2025 by Top Pharmaceutical

Michael Harrison | Precision Medicine | Best Researcher Award

Dr. Michael Harrison, UCSF, United States

Dr. Michael Harrison is a pioneering pediatric surgeon and fetal therapy expert. 🎓 He earned his B.A. from Yale (1965) and M.D. from Harvard Medical School (1969), followed by extensive surgical training at Massachusetts General Hospital and fellowships in pediatric surgery. 🏥 He joined UCSF in 1978, where he became a Full Professor and founded the Fetal Treatment Center. 👶 His groundbreaking work in fetal surgery has earned him numerous accolades, including the Golden Plate Award and presidency of the International Fetal Medicine and Surgery Society. 🌍 Now Professor Emeritus at UCSF, he continues to shape the field of pediatric surgery. ✨

Publication Profile

Scopus

Education

Dr. Michael Harrison 🎓 began his academic journey at Yale University (1961-1965), earning a B.A. before pursuing his M.D. in Medicine at Harvard Medical School (1965-1969) 🏥. He completed his surgical residency at Massachusetts General Hospital (1969-1971) and advanced his expertise as a Postdoctoral Fellow in Allergy & Immunology at the National Institute of Allergy and Infectious Disease (1971-1973) 🧬. Returning to Massachusetts General, he served as a Senior Resident (1973-1974) and Chief Resident (1974-1975) 🔬. Further specializing, he completed fellowships in Pediatric Surgery at Rikshospitalet (1975-1976) 🇳🇴 and Children’s Hospital of Los Angeles (1976-1978) 👶🩺.

Experience

Dr. Michael Harrison 🏥 has been a Founding Member of the International Fetal Medicine and Surgery Society (1981-present) 👶 and has served as its President at the Annual Meeting (1989, 2006) 🎤. He has contributed as a Committee Member for the Medical Advisory Committee of the American Association of Tissue Banks (1993-present) 🧬 and chaired the Committee on Fetal Therapy at APSA (1994-1996) 🏥. A Board Member of the International Society of the Fetus as Patient (1997-present) 🌍, he also consults for the MOMS study (2003-present) 🤰. Since 2010, he has been Vice President of the California Academy of Medicine 📚.

Awards

Dr. Michael Harrison 🏅 has received numerous prestigious honors, including the Golden Plate Award (1982, 1988) 🏆, the William E. Ladd Medal (2010) 🏅, and the Lifetime Achievement Award (2011) 🌟 from the International Fetal Medicine and Surgery Society. He was elected to the Institute of Medicine (2009) 📜 and honored with the Denis Browne Gold Medal (2013) 🏵️. As a celebrated lecturer, he has delivered keynote addresses worldwide 🌍, including at the Nobel Minisymposium on Fetal Medicine (1998) 🎤. His groundbreaking contributions in pediatric surgery have earned him global recognition and lasting influence in the field.

Research Focus

Dr. Michael R. Harrison is a pioneering surgeon and researcher in pediatric surgery and fetal therapy 🏥👶. His work focuses on maternal-fetal surgery, particularly for conditions like esophageal atresia and diaphragmatic hernia. He has contributed to the development of magnetic compression anastomosis 🧲 and other innovative minimally invasive surgical devices 🔬. His research advances the treatment of complex congenital disorders and improves outcomes for newborns. With numerous publications, he has significantly impacted pediatric device clinical trials 📊. Dr. Harrison’s groundbreaking contributions continue to shape the future of pediatric and fetal surgical care 🚼✨.

Publication Top Notes

Pediatric Device Clinical Trials Activity: 1999–2022

Lessons Learned From the First-In-Human Compassionate Use of Connect-EA™ in Ten Patients With Esophageal Atresia

Evaluation of a Magnetic Compression Anastomosis for Jejunoileal Partial Diversion in Rhesus Macaques

Sonographic Predictors of Survival in Fetal Diaphragmatic Hernia

Beyond the gut: spectrum of magnetic surgery devices

The Rearing of Maternal–Fetal Surgery: The Maturation of a Field from Conception to Adulthood

The novel application of an emerging device for salvage of primary repair in high-risk complex esophageal atresia

Esophageal Magnetic Compression Anastomosis in Esophageal Atresia Repair: A PRISMA-Compliant Systematic Review and Comparison with a Novel Approach

An experimental study on long term outcomes after magnetic esophageal compression anastomosis in piglets

Novel device for endoluminal esophageal atresia repair: First-in-human experience

Fatimazahra Sayerh | Antibiotic Resistance | Women Researcher Award

Published on 28/03/202528/03/2025 by Top Pharmaceutical

Fatimazahra Sayerh | Antibiotic Resistance | Women Researcher Award

Mrs. Fatimazahra Sayerh, Faculty of Science and Technology of Mohammedia, Hassan II University, Casablanca, Morocco, Morocco

Fatimazahra Sayerh 🌍🔬 is an environmental science researcher and QHSE specialist with extensive academic and professional experience. She is currently pursuing a Doctorate in Environmental Sciences at Faculté des Sciences et Techniques de Mohammedia (2021-present) after earning a Master’s in Environmental Science and Management (2019-2021) and a Bachelor’s in Water and Environmental Engineering (2018-2019). Fatimazahra has conducted microbiological water analysis at the Institut National d’Hygiène, Rabat, trained professionals in QHSE at Cabinet Certinormes, and contributed to water quality studies at Lydec, Casablanca. She holds a QHSE certification and specializes in water analysis and environmental risk management.

Publication Profile

Scopus

Education

Mrs. Fatimazahra Sayerh has established a strong academic background in environmental sciences 🌍. Her journey began with a Baccalauréat in Physics and Chemistry (2015) followed by a DEUST in Mathematics, Computer Science, and Physics (2015-2018) 💻. She then earned a Bachelor’s in Water and Environmental Engineering (2018-2019) 💧 and a Master’s in Environmental Sciences and Management (2019-2021) 🌱. Currently, she is pursuing a Doctorate in Environmental Sciences (2021-present) at the Faculty of Sciences and Techniques, Mohammedia 🎓. Her diverse academic path reflects her dedication to sustainability and scientific research for a greener future 🌿.

Professional Experience

Mrs. Fatimazahra Sayerh has gained extensive research and professional experience in environmental sciences 🌍. She conducted a research internship at the National Institute of Hygiene, Rabat (Dec 2022 – July 2024) 🏥, specializing in microbiological water analysis 💧. As a trainer at Cabinet Certinormes, Casablanca (Sept 2022 – Dec 2022) 📚she provided QHSE training. Her final-year research projects included physico-chemical water analysis at LNSEP Laboratory, Rabat (April 2021 – July 2021) ⚗️ and efficiency calculations and leakage analysis at Lydec, Casablanca (April 2019 – June 2019) 💦, contributing to sustainable water management and environmental health.

Research Focus

Mrs. Fatimazahra Sayerh specializes in microbiology, environmental health, and antibiotic resistance. Her research focuses on the analysis of pathogenic microorganisms in hospital effluents, utilizing statistical approaches to assess antibiotic resistance patterns and their impact on public health and ecosystems. Through advanced microbial analysis and bioinformatics, she aims to identify critical environmental health risks associated with wastewater contamination. Her work bridges the gap between clinical microbiology and environmental sciences, contributing to sustainable public health strategies and antimicrobial stewardship. Her expertise is essential in combating the rising threat of multidrug-resistant pathogens in aquatic and hospital settings.

Publication Top Notes

Analysis of pathogenic microorganisms in hospital effluents: A statistical approach to understanding antibiotic resistance and environmental health risks

Shuwei Zhou | Gastrointestinal Pharmacology | Best Researcher Award

Published on 27/03/202527/03/2025 by Top Pharmaceutical

Shuwei Zhou | Gastrointestinal Pharmacology | Best Researcher Award

Ms. Shuwei Zhou, Southeast University Zhongda Hospital, China

🔬 Dr. Shuwei Zhou is a distinguished researcher specializing in imaging and nuclear medicine at Zhongda Hospital, Southeast University, China. 🏥 She holds a Ph.D. in Imaging and Nuclear Medicine from Southeast University and a B.A. & Master’s from Hunan University of Chinese Medicine. 🎓 Dr. Zhou has authored numerous high-impact SCI publications 📑 focusing on HCC, LI-RADS, MRI diagnostics, and treatment response. Her contributions include 4 national research projects and 2 patents. 🏆 As a leading expert in radiology and medical imaging, her work advances diagnostic accuracy and patient care in oncology and musculoskeletal disorders. ⚕️✨

Publication Profile

Scopus

Education

Ms. Shuwei Zhou 🎓 has showcased outstanding academic excellence, earning a Ph.D. in Imaging and Nuclear Medicine from the School of Medicine at Southeast University 🏥. Her strong foundation in the field began at Hunan University of Chinese Medicine, where she completed her B.A. and Master’s degree, ranking 1st out of 159 students 🏆. With expertise in molecular and functional imaging, interventional radiology, and pathology 🔬, she has developed a deep understanding of advanced medical diagnostics. Her dedication to research and innovation continues to shape the future of nuclear medicine and imaging technology. 🚀

Experience

Ms. Shuwei Zhou 🔬 has made significant research contributions, publishing in esteemed journals like the American Journal of Roentgenology, Abdominal Radiology, and Frontiers in Immunology 📚. As the first author, she has led groundbreaking studies on MRI contrast agents, diagnostic performance, and treatment response in hepatocellular carcinoma (HCC) 🏥. Her interdisciplinary expertise extends to osteoporosis prediction, the role of gut microbiota in inflammatory bowel disease, and dual-energy CT for bone mineral density 🦴. Through her innovative research, she continues to advance medical imaging and diagnostic precision, making a lasting impact on the field of nuclear medicine. 🚀

Awards

Ms. Shuwei Zhou 🎓 is a distinguished researcher whose impressive portfolio includes first-author contributions in high-impact journals, leadership in scientific projects, and remarkable interdisciplinary expertise 🔬. Her groundbreaking work in imaging and nuclear medicine, particularly in hepatocellular carcinoma research and diagnostic imaging techniques 🏥, has significantly advanced the field. With a strong commitment to innovation and precision in medical diagnostics, she continues to push the boundaries of research. Her achievements make her a highly deserving candidate for the Best Researcher Award 🏆, recognizing her invaluable contributions to the future of medical imaging and nuclear medicine. 🚀

Research Focus

Shuwei Zhou’s research primarily focuses on medical imaging 🏥📡 and oncology, with a particular emphasis on hepatocellular carcinoma (HCC) 🏨🧬 and non-radiation treatment response assessment. She is actively involved in the development of diagnostic algorithms 📊🔍, such as the LI-RADS Nonradiation Treatment Response Algorithm, and predictive models like the TRACE Model, which help evaluate the effectiveness of transarterial chemoembolization (TACE) 💉⚕️ in patients with unresectable liver cancer. Her contributions aim to enhance precision medicine 🎯 and optimize clinical decision-making for better patient outcomes.

Publication Top Notes

LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma

Xandra Breakefield | Gene Therapy | Best Researcher Award

Published on 27/03/202527/03/2025 by Top Pharmaceutical

Xandra Breakefield | Gene Therapy | Best Researcher Award

Prof. Dr. Xandra Breakefield, Massachusetts General Hospital/Harvard Medical School, United States

Prof. Dr. Xandra Breakefield is a pioneering geneticist and neuroscientist specializing in gene therapy and extracellular vesicle research. She earned her Ph.D. from Georgetown University and trained at NIH under Nobel Laureate Dr. Marshall Nirenberg. A Harvard Medical School professor and Massachusetts General Hospital researcher, she has made groundbreaking contributions to neurogenetics and dystonia. Recognized with numerous prestigious awards 🏆, including the Mika Salpeter Lifetime Achievement Award, she ranks among the world’s top scientists. A leader in gene and cell therapy, she serves on advisory boards worldwide 🌍, shaping the future of biomedical research.

Publication Profile

orcid

Education

Prof. Dr. Xandra Breakefield 🎓 embarked on her academic journey with an A.B. in Biology from Wilson College (1960-1965), graduating cum laude for her outstanding performance. During this period, she also enriched her knowledge at American University (1964-1965), deepening her expertise in biology 🧬. Her passion for microbial genetics led her to pursue a Ph.D. at Georgetown University (1967-1971), where she specialized in microbial genetics 🦠. This strong educational foundation set the stage for her groundbreaking contributions to the field, establishing her as a distinguished researcher in genetics and molecular biology. 🌟

Professional Experience

Prof. Dr. Xandra Breakefield 🧬 has had an illustrious career in genetics and neurology. She has been a Geneticist at Massachusetts General Hospital’s Radiology Service since 2002 and a Professor of Neurology at Harvard Medical School since 1996. Previously, she held key roles in molecular neurogenetics at Massachusetts General Hospital 🏥 and directed the Division of Molecular Neurogenetics at the Eunice Kennedy Shriver Center. Her academic journey includes faculty positions at Yale University and Georgetown University 📚. Early in her career, she trained under Nobel Laureate Dr. Marshall Nirenberg at NIH, shaping her expertise in biochemical genetics. 🌟

Awards

Prof. Dr. Xandra Breakefield 🧬 has received numerous prestigious awards for her groundbreaking contributions to neuroscience and genetics. She earned the McKnight Neuroscience Development Award (1982-1984) and two Javits Neuroscience Investigator Awards (1985-1992, 1995-2002). She was honored with an Honorary Doctorate from Wilson College (1991) and an Honorary Master’s Degree from Harvard Medical School (1996) 🎓. Recognized globally, she received the Mika Salpeter Lifetime Achievement Award (2013) and the NIH Director’s WALS Speaker Award (2017). Ranked among the Top 1000 Female Scientists in the World (2022, 2024), her work continues to shape modern molecular medicine. 🌟

Research Focus

Prof. Dr. Xandra O. Breakefield focuses on neuroscience, gene therapy, and extracellular vesicles 🧠🧬🩸. Her research explores how extracellular vesicles facilitate cell-to-cell communication and their potential for delivering gene therapies to treat neurological disorders and cancers. She also investigates glioblastoma, a highly aggressive brain tumor, using cortical organoids 🧪🔬 to study cell-state heterogeneity and intercellular transfer. Her work has significant implications for precision medicine and targeted therapies 🎯💊. As a leading expert in the field, she collaborates on innovative projects integrating genomics, bioengineering, and molecular biology to advance treatments for brain diseases.

Publication Top Notes

Extracellular vesicles for the delivery of gene therapy

Data from Glioblastoma Cortical Organoids Recapitulate Cell-State Heterogeneity and Intercellular Transfer

RNA delivery by extracellular vesicles in mammalian cells and its applications

Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor Progression

Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell Function

Exosome/microvesicle content is altered in leucine‐rich repeat kinase 2 mutant induced pluripotent stem cell‐derived neural cells

Glioma-Derived miRNA-Containing Extracellular Vesicles Induce Angiogenesis by Reprogramming Brain Endothelial Cells

Reda Abdel-Hameed | Pharmaceutical Chemistry | Best Researcher Award

Published on 27/03/202527/03/2025 by Top Pharmaceutical

Reda Abdel-Hameed | Pharmaceutical Chemistry | Best Researcher Award

Prof. Dr. Reda Abdel-Hameed, University of Hail, Egypt

Prof. Dr. Reda Abdel-Hameed is a distinguished chemist specializing in applied physical chemistry. He earned his B.Sc. (1998), M.Sc. (2003), and Ph.D. (2006) from Al-Azhar University, Cairo. With over two decades in academia, he has served as a professor at Al-Azhar University and an associate professor at the University of Hail, Saudi Arabia. His prolific research includes 134 published papers on nanotechnology, drug design, and environmental chemistry. A leader in scientific innovation, he continues to shape the future of chemistry through groundbreaking studies and mentorship.

Publication Profile

Google Scholar

Education

Prof. Dr. Reda Abdel-Hameed 🎓 is a distinguished chemist with a strong academic background. He earned his B.Sc. in Chemistry in 1998 with an Excellent with Honor degree 🏅, followed by an M.Sc. in Applied Organic Chemistry in 2003 and a Ph.D. in Applied Physical Chemistry in 2006. His academic career began as a Demonstrator at Al-Azhar University (1998-2003) and progressed to Lecturer (2003-2006), Assistant Professor (2006-2012), and Associate Professor (2012-2017). He also served at Hail University, KSA (2009-2012). Since 2017, he has been a Full Professor at Al-Azhar University, contributing significantly to the field of chemistry 🔬.

Experience

Prof. Dr. Reda Abdel-Hameed 📚 has an extensive teaching portfolio in chemistry across Al-Azhar University and Hail University. At Al-Azhar, he has taught courses in Physical Chemistry, Electrochemistry, Polymer Science, Industrial Chemistry, and more 🔬. At Hail University, he covered Applied Physical Chemistry, Quantum Chemistry, Medical Chemistry, and Petroleum Chemistry ⛽. Additionally, he played a key role in developing course specifications and descriptions. His contributions extend to authorship, with books like Introduction to Organic Chemistry, Applied Electrochemistry, and Nanocomposites as Corrosion Inhibitors 📖. His dedication to chemistry education continues to inspire students worldwide 🌍.

Awards

Prof. Dr. Reda Abdel-Hameed 🌍 is a globally recognized scientist, ranked among the world’s top 2% by Stanford University and Elsevier from 2019 to 2023 📊. His excellence in academia has earned him numerous accolades, including the Ideal Student Prize (1996-1997) 🏆, the Faculty of Science Award for Academic Affairs (2012), and the Excellence in Teaching Award (2017) 🎓. He was also honored for integrating technology into higher education (2010) and recognized as the Best Coordinator for Student Activities at Hail University (2016). A proud member of the Royal Society of Chemistry (RSC) 🔬, he continues to make remarkable contributions.

Research Focus

Prof. Dr. Reda S. Abdel-Hameed specializes in corrosion science and electrochemical applications ⚡🔬. His research focuses on developing corrosion inhibitors 🛡️ for metals, particularly in acidic and marine environments. He explores green chemistry approaches 🌱, including eco-friendly inhibitors derived from expired drugs 💊, polymers 🏗️, and heterocyclic compounds 🧪. His work advances electrochemical techniques for evaluating materials’ durability and protection in industrial applications 🏭. With significant contributions to nanotechnology-based inhibitors 🧬 and adsorption studies, his research benefits sectors like petrochemicals, metallurgy, and coatings 🏗️. His expertise in analytical electrochemistry helps mitigate corrosion-related challenges, ensuring sustainability and efficiency.

Publication Top Notes

Analytical application using modern electrochemical techniques

Ranitidine drugs as non-toxic corrosion inhibitors for mild steel in hydrochloric acid medium

Preparation of green cardanol-based epoxy and hardener as primer coatings for petroleum and gas steel in marine environment

Aminolysis of polyethylene terephthalate waste as corrosion inhibitor for carbon steel in HCl corrosive medium

Effect of expired drugs as corrosion inhibitors for carbon steel in 1M HCL solution

2-(2, 6-dichloranilino) phenyl acetic acid drugs as eco-friendly corrosion inhibitors for mild steel in 1M HCl

Expired Voltaren drugs as corrosion inhibitor for aluminium in hydrochloric acid

Nano-composite as corrosion inhibitors for steel alloys in different corrosive media

Corrosion inhibition and adsorption properties of some heterocyclic derivatives on C-steel surface in HCl

Bekri Melka Abdo | Drug Discovery and Development | Top Pharmaceutical Scientist Award

Published on 26/03/202526/03/2025 by Top Pharmaceutical

Bekri Melka Abdo | Drug Discovery and Development | Top Pharmaceutical Scientist Award

Mr. Bekri Melka Abdo, Ethiopian Institute of Agricultural Research, Ethiopia

Bekri Melka Abdo is a dedicated organic chemist specializing in natural product chemistry 🌿. With expertise in plant sample collection, extraction, compound isolation, and structure elucidation, he focuses on bioactive compounds from Ethiopia’s medicinal and aromatic plants. His research contributes to developing natural product-based treatments for leishmaniasis 🦠. He has two published journal articles, an h-index of 7, a Google patent, and an ISBN-registered book 📖. Actively engaged in research and consultancy, Bekri is committed to innovative drug discovery and advancing natural product chemistry for global health.

Publication Profile

orcid

Education

Bekri Melka Abdo is a dedicated professional in organic chemistry 🧪, specializing in natural product chemistry 🌿. His expertise encompasses plant sample collection and preparation, extraction, compound isolation, and structure elucidation. He is skilled in qualitative and quantitative analysis, as well as biological activity determination of natural products extracted from various aromatic and medicinally significant 🌱 exotic and endemic plant species of Ethiopia. With a strong foundation in the field, he contributes to the discovery and characterization of bioactive compounds, supporting advancements in medicine, pharmaceuticals, and biotechnology 🔬. His research plays a vital role in exploring Ethiopia’s rich botanical resources.

Experience

Bekri Melka Abdo is a passionate researcher in natural product chemistry 🌿, with a strong track record of research and innovation 🔬. He has successfully completed two research projects and maintains an h-index of 7 📊. His contributions extend to industry consultancy and collaborative projects, showcasing his impact in the field. He has authored a book with an ISBN 📖 and has a Google patent pending. His work is recognized in SCI and Scopus-indexed journals 🏅, with two publications. Actively engaged in editorial roles and professional memberships, he continues to drive scientific advancements in bioactive compound discovery.

Award

Bekri Melka Abdo, with his early career achievements and promising research in natural product chemistry 🌿, is an ideal candidate for the Young Scientist Award 🏆. His dedication to bioactive compound discovery, coupled with his impactful contributions to scientific research and innovation 🔬, highlights his potential for future breakthroughs. With a strong foundation in natural product extraction, analysis, and biological activity determination, he is paving the way for new discoveries in medicine and biotechnology 💊. This award category recognizes emerging researchers like Mr. Abdo, whose work demonstrates both excellence and the promise of transformative scientific advancements.

Research Focus

Mr. Bekri Melka Abdo specializes in phytochemistry and antiparasitic drug discovery, focusing on the bioassay-guided isolation of natural compounds for therapeutic applications. His research on dehydrocostus lactone from Echinops kebericho highlights its potential as a leishmanicidal drug 🦟⚕️. His work integrates natural product chemistry, pharmacognosy, and infectious disease research, contributing to novel drug development against leishmaniasis. By combining traditional medicinal plants with modern bioassays, he advances the search for effective, plant-derived antiparasitic treatments 🌱🔬. His research holds promise for addressing neglected tropical diseases through sustainable and nature-inspired therapies.

Publication Top Notes

Bioassay-guided isolation of dehydrocostus lactone from Echinops kebericho as a leishmanicidal drug

Ewa Obuchowicz | Pharmacology | Best Researcher Award

Published on 26/03/202526/03/2025 by Top Pharmaceutical

Ewa Obuchowicz | Pharmacology | Best Researcher Award

Prof. Ewa Obuchowicz, Medical University of Silesia, Poland

Prof. Ewa Obuchowicz is the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia. She earned her M.Sc. in 1979, Ph.D. in 1985, became an Associate Professor in 2001, and a Professor in 2011. Her research focuses on psychotropic drugs, neuropeptides, cytokines, and glioblastoma therapy 🧠🔬. She has authored 89 scientific papers, with over 2,000 citations and an h-index of 20. A recipient of multiple awards 🏆, she is an esteemed member of the Polish Pharmacological Society.

Publication Profile

Scopus

Education

Prof. Ewa Obuchowicz 🎓 is a distinguished expert in pharmacology, with an impressive academic journey spanning decades. She earned her M.Sc. in 1979, followed by a Ph.D. in 1985, and attained full professorship in 2011. As the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia 🏥, she exemplifies leadership and dedication to advancing medical research. Her extensive contributions and unwavering commitment to the field make her a strong candidate for the Best Researcher Award 🏆, highlighting her impact on academia and scientific progress.

Experience

Prof. Ewa Obuchowicz 🔬 is a renowned researcher specializing in psychotropic drug mechanisms, neuropeptides, cytokines, and glial cell protein expression. Her work delves into the complex interplay between stress, immunostimulation, and neurotrophic factors 🧠, shedding light on crucial neurological processes. Additionally, she has explored the role of the endocannabinoid system 🌿 and contributed to developing innovative adjuvant therapies for glioblastoma 🎗️. Her groundbreaking research plays a vital role in advancing medical and pharmacological sciences, solidifying her reputation as a distinguished scientist in the field. Her dedication continues to shape the future of neuropharmacology and therapeutic innovation.

Scientific Achievements

Prof. Ewa Obuchowicz 📚 has made a remarkable impact on the scientific community with 89 full-length publications, 71 of which have been cited over 2,000 times. With an h-index of 20 (Scopus) 📊, her research has gained widespread recognition. Notably, five of her papers have been cited over 100 times, highlighting their profound influence. Beyond research articles, she has contributed to authoritative pharmacology handbooks 📖, further solidifying her scholarly excellence. Her outstanding publication record and significant contributions to the field make her a deserving candidate for the award 🏆, reflecting her dedication to advancing pharmacological sciences.

Professional Memberships

Prof. Ewa Obuchowicz 🤝 is an active member of the Polish Pharmacological Society, where she contributes to professional discussions and advancements in pharmacology. Through her engagement with research organizations 🏛️, she fosters collaboration and drives progressive scientific discoveries. Her dedication to the field extends beyond her own research, as she actively participates in shaping the future of pharmacology through knowledge exchange and professional networking. By staying at the forefront of scientific discourse, she continuously enhances the impact of her work, reinforcing her role as a key contributor to the advancement of medical and pharmacological sciences.

Awards

Prof. Ewa Obuchowicz 🏅 has received prestigious recognition for her outstanding contributions to medical and pharmacological research. She has been honored with two Scientific Awards from the Minister of Health and Social Welfare 🏆 and thirteen Scientific Awards from the Rector of the Medical University of Silesia in Katowice 🎖️. These accolades reflect her dedication, innovation, and impact in the field. Her groundbreaking research and scholarly achievements continue to shape the future of pharmacology, further solidifying her candidacy for the Best Researcher Award 🏅 and reinforcing her status as a leading figure in medical science.

Research Focus

Professor Ewa Obuchowicz is a distinguished neuroscientist specializing in psychopharmacology 🧠💊, with a research focus on depression, stress, and the endocannabinoid system. Her work explores the mechanisms of antidepressants, particularly escitalopram, and their effects on neurotransmission, gene expression, and behavioral responses. She has contributed significantly to preclinical models of stress and mood disorders, investigating the role of neuropeptides, oxytocin, and the hypothalamus-pituitary-gonadal (HPG) axis 🔬📊. Additionally, her research extends to neuro-oncology, examining glioblastoma treatments. Through her studies, she aims to advance mental health therapeutics and improve understanding of stress-induced disorders.

Publication Top Notes

Escitalopram reverses anxiety-like and despair behavior and affects endocannabinoid-related genes expression in the brain of adolescent male rats subjected to early life stress

Acute Stress Affects the Relaxin/Insulin-Like Family Peptide Receptor 3 mRNA Expression in Brain of Pubertal Male Wistar Rats

How depression and antidepressant drugs affect endocannabinoid system?—review of clinical and preclinical studies

A Dot-Blot Screening for Identifying the Temozolomide-Regulated Proteins as Potential Targets for Glioma Multi-OMICS Studies

Escitalopram alters the hypothalamic OX system but does not affect its up-regulation induced by early-life stress in adult rats.

Neuropeptides as regulators of the hypothalamus-pituitary-gonadal (HPG) axis activity and their putative roles in stress-induced fertility disorders

Glucose Influences the Response of Glioblastoma Cells to Temozolomide and Dexamethasone

May application of oxytocin be relevant in the therapy of perinatal mental disorders?

Sabine Asmus | Pharmacodynamics | Best Researcher Award

Published on 26/03/202526/03/2025 by Top Pharmaceutical

Sabine Asmus | Pharmacodynamics | Best Researcher Award

Prof. Dr. Sabine Asmus, Sorabistik Leipzig, Germany

Born in Berlin, Prof. Dr. Sabine Asmus is a distinguished linguist specializing in Celtic, English, and Slavic languages. She earned her PhD in translation studies from Humboldt University and has lectured in Germany, Austria, Poland, and beyond. She founded Poland’s first Celtic Department and the journal Res Celticae. A prolific researcher in lexicology and language revitalization, she has worked extensively in Wales and now contributes to the Sorbian Department at Leipzig University. A frequent media contributor, she continues to bridge linguistic and cultural gaps through research, teaching, and translation. 🎓

Publication Profile

orcid

Academic Excellence

Prof. Dr. Sabine Asmus is a distinguished scholar in linguistics, specializing in Celtic and English Studies. 📚 Her academic journey began with a PhD in translation studies from Humboldt-University Berlin, showcasing her dedication to research and education. 🌍 With a career spanning Germany, Wales, Austria, Poland, and France, she has made a global impact in language studies. 🏛️ Her work reflects a deep commitment to linguistic research, cultural preservation, and knowledge dissemination. ✍️ Through her extensive contributions, Prof. Dr. Asmus continues to shape the field of linguistics, inspiring scholars and students worldwide.

Experience

Prof. Dr. Sabine Asmus is a trailblazer in linguistics, renowned for establishing the first Celtic Department in Poland and the Department of Celtic Languages and Cultures at Szczecin University. 🎓 Her pioneering work in lexicology, lexicography, and language revitalization, especially with the Sorbian languages, showcases her innovative approach to research. 📖🔍 Beyond academia, she actively contributes to media and public discourse, making complex linguistic topics accessible to wider audiences. 🎙️🗣️ Her dedication to preserving and promoting endangered languages underscores her impact in the field, inspiring scholars and language enthusiasts worldwide. 🌍✨

Academic Leadership

Prof. Dr. Sabine Asmus is a dedicated academic leader, mentoring numerous BA, MA, and PhD scholars with a passion for fostering research excellence. 🎓📚 Her commitment to linguistic diversity and student development highlights her profound impact on the academic community. 🌍✍️ Beyond the classroom, she actively engages with the public through media contributions, promoting language preservation and awareness. 🎙️🗣️ Her influence in academia and beyond makes her a strong candidate for the Best Researcher Award, recognizing her outstanding contributions to linguistic studies and education. 🏆

Research Focus

Prof. Dr. Sabine Asmus is a distinguished linguist specializing in Celtic languages, particularly Welsh and Irish 🏛️📜. Her research encompasses phonetics, phonology, syntax, and semantic evolution 🗣️🔤. She has extensively studied Welsh verbal nouns, aspectuality, consonant mutations, and vowel length, alongside comparative linguistic studies between Celtic and Slavic languages 🌍📖. She also explores language planning and revitalization strategies, with a keen interest in color semantics in Welsh and Irish 🎨📝. Her work includes books, journal articles, and conference papers, making significant contributions to linguistics, phonetics, and language education 📚🏅.

Publication Top Notes

The Welsh Verbal Noun

The Early Concept of the Celtic Colour Term glas in Welsh and Irish and its Later Semantic Diversification / Sabine Asmus & Mark Ó Fionnáin

Kak wjele kompetentnych powědarjow dolnoserbšćiny jo w lěśe 2024? Pówoblicenje na zakłaźe aktualnych datow

Review: Grammatikübungsbuch Walisisch / Sabine Asmus

Aspectuality in Welsh

ABDUL ABDUZ ZAHIR | Nanomedicine | Best Researcher Award

Published on 25/03/202525/03/2025 by Top Pharmaceutical

ABDUL ABDUZ ZAHIR | Nanomedicine | Best Researcher Award

Dr. ABDUL ABDUZ ZAHIR, C. Abdul Hakeem College, Autonomous, India

Dr. ABDUL ABDUZ ZAHIR🎓 is a dedicated zoologist with a Ph.D. from Thiruvalluvar University (2015) and over 14 years of teaching experience. Passionate about research, he has published extensively, focusing on nanotechnology, antidiabetic drug encapsulation, and biolarvicidal compounds. 🦠 He has organized multiple national and international conferences, actively mentors students, and contributes to social causes. 🏅 His accolades include the Special Jury Award (2023) and university ranks. As a course coordinator, he promotes vermicomposting technology. 🌱 Committed to innovation, he aims to develop low-cost medicines for malaria and diabetes. 💊

Publication Profile

Google Scholar

Education

Dr. Abdul Abduz Zahir 🎓 is a distinguished scholar in zoology, holding a Ph.D. from C. Abdul Hakeem College, Thiruvalluvar University, completed in June 2015. His academic journey began with a B.Sc. (2006), followed by an M.Sc. (2008) and an M.Phil. (2009) from the same institution. 📚 Prior to higher education, he completed his SSLC at Islamiah Boys Higher Secondary School, Melvisharam (2002), and HSLC at Govt. Muslim Higher Secondary School, Vellore (2000). 🏫 With a strong foundation in zoological sciences, Dr. Zahir continues to contribute significantly to the field through research and academic excellence. 🔬

Experience

Dr. Abdul Abduz Zahir 🎓 is an experienced educator and researcher with 14 years of teaching expertise, guiding both undergraduate and postgraduate students. 📚 His passion for zoology extends beyond the classroom, with 15 years of dedicated research, reflected in numerous publications. 📝🔬 His contributions to scientific literature highlight his commitment to advancing knowledge in his field. For a deeper insight into his research, his published articles can be accessed through the provided link. 🌍📖 With a strong academic and research background, Dr. Zahir continues to inspire students and contribute to the scientific community. ✨

Awards

Dr. Abdul Abduz Zahir 🎓 has received numerous accolades for his academic excellence and contributions. He was honored with the “Special Jury Award” 🏆 by AMP on September 5, 2023. His outstanding Ph.D. research earned him a Merit Stipend 💰 from the Director of Collegiate Education, Chennai (2010–2012). 🌟 In April 2008, he secured the 6th Rank in Post-Graduate Examinations at Thiruvalluvar University. 🏅 Additionally, he was awarded Silver Medals 🥈 for Proficiency in Urdu in the university exams of April 2003 and 2004. His achievements reflect his dedication to academia and research. 📚✨

Research Focus

Dr. Abdul Abduz Zahir is a distinguished researcher in nanotechnology-based biopesticides 🦠🌱 and vector control 🦟🚫. His work primarily focuses on green nanotechnology 🧪🌿, involving the biosynthesis of nanoparticles using plant and microbial extracts for antimicrobial 🦠⚔️, antiparasitic 🦟🛑, and insecticidal applications 🐜💀. His research significantly contributes to eco-friendly pest management 🌍✅ and biomedical applications 🏥🔬. He has co-authored several highly cited studies on silver and titanium dioxide nanoparticles 🏗️⚛️, exploring their potential in larvicidal, ovicidal, and antimicrobial activities 🔬🦟. His findings have implications for public health and sustainable pest control.